New therapeutic agents in diabetic nephropathy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

New therapeutic agents in diabetic nephropathy

Published:2017-01-01 Issue:1 Volume:32 Page:11-25
ISSN:1226-3303
Container-title:The Korean Journal of Internal Medicine
language:en
Short-container-title:Korean J Intern Med

Author:

Kim Yaeni,Park Cheol Whee

Funder

National Research Foundation of Korea

Ministry of Education, Science and Technology

Catholic University of Korea

Publisher

Korean Association of Internal Medicine

Link

http://kjim.org/upload/kjim-2016-174.pdf

Reference79 articles.

1. Chronic kidney disease: global dimension and perspectives

2. Chronic Kidney Disease and the Risk for Cardiovascular Disease, Renal Replacement, and Death in the United States Medicare Population, 1998 to 1999

3. Longitudinal Follow-up and Outcomes Among a Population With Chronic Kidney Disease in a Large Managed Care Organization

4. The Prevalence of Chronic Kidney Disease (CKD) and the Associated Factors to CKD in Urban Korea: A Population-based Cross-sectional Epidemiologic Study

5. Major changes and improvements of dialysis therapy in Korea: review of end-stage renal disease registry

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research Progress of Diabetic Kidney Disease with Traditional Chinese Medicine;Journal of Contemporary Medical Practice;2024-08-21

2. Qizhi Jiangtang capsule ( 芪蛭 (sic) 糖胶囊) activates podocyte autophagy in diabetic kidney disease by inhibiting phosphatidylinositol 3-kinase/protein kinase B/mammalian target of rapamycin pathways;J TRADIT CHIN MED;2023

3. Agomelatine improves streptozotocin-induced diabetic nephropathy through melatonin receptors/SIRT1 signaling pathway;International Immunopharmacology;2023-02

4. Berberine protects diabetic nephropathy by suppressing epithelial-to-mesenchymal transition involving the inactivation of the NLRP3 inflammasome;Renal Failure;2022-05-26

5. Glomerular filtration rate as a kidney outcome of diabetic kidney disease: a focus on new antidiabetic drugs;The Korean Journal of Internal Medicine;2022-05-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3